The decision to list a patient for liver transplantation or to actually perform that life-saving procedure lies with the physicians and staff of each transplant center. However, the HighTide study of HTD1801 excludes patients with very advanced liver disease (known as decompensated cirrhosis), so it is highly unlikely that anyone in immediate need of a transplant would be in the study. The components of HTD1801 are rapidly cleared by the body and should not provide an obstacle to anyone needing a transplant.
All study-related visits, laboratory tests, and study-related medication will be provided at no cost. Travel reimbursement may be available.
If you are interested in participating in this study, have questions, please email email@example.com. One of our team members will respond to you personally within 2 days.
For a complete list of medical centers conducting the HTD1801 clinical study, please see the clinical study listing on www.clinicaltrials.gov.